| Primary |
| Contraception |
30.3% |
| Endometriosis |
14.1% |
| Oral Contraception |
13.1% |
| Asthma |
6.1% |
| Menorrhagia |
5.1% |
| Menstruation Irregular |
5.1% |
| Bipolar Disorder |
4.0% |
| Dysmenorrhoea |
4.0% |
| Chronic Sinusitis |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Hormone Replacement Therapy |
2.0% |
| Menstrual Cycle Management |
2.0% |
| Migraine |
2.0% |
| Off Label Use |
2.0% |
| Acne |
1.0% |
| Immunisation |
1.0% |
| Menometrorrhagia |
1.0% |
| Menstrual Disorder |
1.0% |
| Mitral Valve Prolapse |
1.0% |
| Ovarian Cyst |
1.0% |
|
| Metrorrhagia |
18.0% |
| Vaginal Haemorrhage |
9.8% |
| Menorrhagia |
8.2% |
| Unintended Pregnancy |
6.6% |
| Weight Increased |
6.6% |
| Deep Vein Thrombosis |
4.9% |
| Menometrorrhagia |
4.9% |
| Rash |
4.9% |
| Sinus Disorder |
4.9% |
| Thrombosis |
4.9% |
| Endometrial Disorder |
3.3% |
| No Adverse Event |
3.3% |
| Product Quality Issue |
3.3% |
| Pulmonary Embolism |
3.3% |
| Respiratory Disorder |
3.3% |
| Vomiting |
3.3% |
| Acne |
1.6% |
| Alopecia |
1.6% |
| Atrophic Vulvovaginitis |
1.6% |
| Breast Tenderness |
1.6% |
|
| Secondary |
| Asthma |
16.2% |
| Contraception |
16.2% |
| Endometriosis |
13.5% |
| Drug Use For Unknown Indication |
10.8% |
| Bipolar Disorder |
8.1% |
| Off Label Use |
5.4% |
| Dysmenorrhoea |
2.7% |
| Hormone Replacement Therapy |
2.7% |
| Migraine |
2.7% |
| Mitral Valve Prolapse |
2.7% |
| Oral Contraception |
2.7% |
| Ovarian Cyst |
2.7% |
| Pain |
2.7% |
| Pelvic Pain |
2.7% |
| Post Coital Contraception |
2.7% |
| Uterine Leiomyoma |
2.7% |
| Uterine Spasm |
2.7% |
|
| Sinus Disorder |
16.7% |
| Treatment Noncompliance |
16.7% |
| Loss Of Consciousness |
11.1% |
| Metrorrhagia |
11.1% |
| Breast Pain |
5.6% |
| Irritability |
5.6% |
| Night Sweats |
5.6% |
| Pregnancy |
5.6% |
| Product Quality Issue |
5.6% |
| Skin Tightness |
5.6% |
| Vaginal Haemorrhage |
5.6% |
| Weight Increased |
5.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.4% |
| Contraception |
12.6% |
| Migraine |
10.7% |
| Multiple Sclerosis |
6.8% |
| Anxiety |
5.8% |
| Drug Use For Unknown Indication |
5.8% |
| Seasonal Allergy |
5.8% |
| Asthma |
3.9% |
| Crohn's Disease |
3.9% |
| Premenstrual Syndrome |
3.9% |
| Dyspepsia |
2.9% |
| Insomnia |
2.9% |
| Oral Contraception |
2.9% |
| Endometriosis |
1.9% |
| Fatigue |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Headache |
1.9% |
| Menorrhagia |
1.9% |
| Obsessive-compulsive Disorder |
1.9% |
| Pain |
1.9% |
|
| Rash |
9.7% |
| Thrombosis |
9.7% |
| Vomiting |
9.7% |
| Weight Increased |
9.7% |
| Pain |
6.5% |
| Tonsillitis |
6.5% |
| Vaginal Haemorrhage |
6.5% |
| Abdominal Pain |
3.2% |
| Accidental Exposure |
3.2% |
| Cold Type Haemolytic Anaemia |
3.2% |
| Hyperhidrosis |
3.2% |
| Incorrect Dose Administered |
3.2% |
| Injection Site Reaction |
3.2% |
| Malaise |
3.2% |
| Metrorrhagia |
3.2% |
| Mood Altered |
3.2% |
| Pancreatitis |
3.2% |
| Pharyngitis Streptococcal |
3.2% |
| Stress |
3.2% |
| Surgery |
3.2% |
|
